Trials / Completed
CompletedNCT00367120
Zmax Compared to Augmentin in Sinusitis
A Multicenter, Randomized, Open Label Comparative Study Of Azithromycin Extended Release (ZMAX) Versus Amoxicillin/Clavulanate Potassium In Subjects With Acute Bacterial Sinusitis (ABS) In A Physician Practice Environment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 762 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will enroll patients with Bacterial Sinusitis who will be treated with either Zmax (Azithromycin Extended Release) or Augmentin (Amoxicillin/Clavulanate). The purpose of the study is to compare early resolution of symptoms between the two treatments. Patients will report resolution of their sinusitis symptoms through a daily questionnaire. There will be two follow-up telephone interviews on days 12 and 28 to evaluate quality of life, satisfaction with therapy, and use of healthcare services.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin Extended Release | |
| DRUG | Amoxicillin/Clavulanate |
Timeline
- Start date
- 2006-06-01
- Completion
- 2007-02-01
- First posted
- 2006-08-22
- Last updated
- 2010-03-16
Source: ClinicalTrials.gov record NCT00367120. Inclusion in this directory is not an endorsement.